These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20138088)

  • 1. RS-0406 arrests amyloid-beta oligomer-induced behavioural deterioration in vivo.
    O'Hare E; Scopes DI; Treherne JM; Norwood K; Spanswick D; Kim EM
    Behav Brain Res; 2010 Jun; 210(1):32-7. PubMed ID: 20138088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro.
    Nakagami Y; Nishimura S; Murasugi T; Kaneko I; Meguro M; Marumoto S; Kogen H; Koyama K; Oda T
    Br J Pharmacol; 2002 Nov; 137(5):676-82. PubMed ID: 12381681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
    Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
    Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.
    Carrillo-Mora P; Méndez-Cuesta LA; Pérez-De La Cruz V; Fortoul-van Der Goes TI; Santamaría A
    Behav Brain Res; 2010 Jul; 210(2):240-50. PubMed ID: 20219555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity.
    Scopes DI; O'Hare E; Jeggo R; Whyment AD; Spanswick D; Kim EM; Gannon J; Amijee H; Treherne JM
    Br J Pharmacol; 2012 Sep; 167(2):383-92. PubMed ID: 22913627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.
    Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A
    Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of Z-ligustilide against amyloid beta-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains.
    Kuang X; Du JR; Chen YS; Wang J; Wang YN
    Pharmacol Biochem Behav; 2009 Jun; 92(4):635-41. PubMed ID: 19324070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
    Rowan MJ; Klyubin I; Wang Q; Anwyl R
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25-35) oligomer-induced toxicity.
    Tarozzi A; Morroni F; Merlicco A; Bolondi C; Teti G; Falconi M; Cantelli-Forti G; Hrelia P
    Neurosci Lett; 2010 Apr; 473(2):72-6. PubMed ID: 20152881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. {beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents.
    Michaelis ML; Ansar S; Chen Y; Reiff ER; Seyb KI; Himes RH; Audus KL; Georg GI
    J Pharmacol Exp Ther; 2005 Feb; 312(2):659-68. PubMed ID: 15375176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.
    Kim CY; Lee C; Park GH; Jang JH
    Arch Pharm Res; 2009 Jun; 32(6):869-81. PubMed ID: 19557365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.
    Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL
    Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.
    Walsh DM; Klyubin I; Shankar GM; Townsend M; Fadeeva JV; Betts V; Podlisny MB; Cleary JP; Ashe KH; Rowan MJ; Selkoe DJ
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1087-90. PubMed ID: 16246051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-beta peptide (1-40) in rats.
    Nguyen PT; Kimura T; Ho SA; Tran AH; Ono T; Nishijo H
    Hippocampus; 2007; 17(6):443-55. PubMed ID: 17397046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity.
    Sultana R; Ravagna A; Mohmmad-Abdul H; Calabrese V; Butterfield DA
    J Neurochem; 2005 Feb; 92(4):749-58. PubMed ID: 15686476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.